Bio-Techne (TECH) Property, Plant & Equipment (Net) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.21% |
| Dec 31, 2025 | 3.68% |
| Sep 30, 2025 | 4.63% |
| Jun 30, 2025 | 6.80% |
| Mar 31, 2025 | 8.84% |
| Dec 31, 2024 | 8.73% |
| Sep 30, 2024 | 10.13% |
| Jun 30, 2024 | 10.27% |
| Mar 31, 2024 | 10.90% |
| Dec 31, 2023 | 10.02% |
| Sep 30, 2023 | 9.60% |
| Jun 30, 2023 | 9.25% |
| Mar 31, 2023 | 9.38% |
| Dec 31, 2022 | 10.08% |
| Sep 30, 2022 | 10.37% |
| Jun 30, 2022 | 10.56% |
| Mar 31, 2022 | 10.57% |
| Dec 31, 2021 | 9.93% |
| Sep 30, 2021 | 9.13% |
| Jun 30, 2021 | 9.45% |
| Mar 31, 2021 | 8.28% |
| Dec 31, 2020 | 7.85% |
| Sep 30, 2020 | 7.61% |
| Jun 30, 2020 | 6.39% |
| Mar 31, 2020 | 5.80% |
| Dec 31, 2019 | 5.66% |
| Sep 30, 2019 | 5.14% |
| Jun 30, 2019 | 20.61% |
| Mar 31, 2019 | 4.49% |
| Dec 31, 2018 | 4.75% |
| Sep 30, 2018 | 5.26% |
| Jun 30, 2018 | 18.85% |
| Mar 31, 2018 | 6.30% |
| Dec 31, 2017 | 6.48% |
| Sep 30, 2017 | 7.59% |
| Jun 30, 2017 | 7.58% |
| Mar 31, 2017 | 6.91% |
| Dec 31, 2016 | 6.88% |
| Sep 30, 2016 | 7.24% |
| Jun 30, 2016 | 6.77% |
| Mar 31, 2016 | 7.26% |
| Dec 31, 2015 | 7.11% |
| Sep 30, 2015 | 6.64% |
| Jun 30, 2015 | 5.90% |